Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Language | Translation |
---|---|
English | Withdrawal state with delirium |
French | Troubles mentaux et du comportement liés à l'utilisation d'opiacés : syndrome de sevrage avec delirium |
Level | Code | Title | |
---|---|---|---|
1 | V | Mental and behavioural disorders | |
2 | F10-F19 | Mental and behavioural disorders due to psychoactive substance use | |
3 | F11 | Mental and behavioural disorders due to use of opioids | |
4 | F11.4 | Withdrawal state with delirium |
A condition where the withdrawal state as defined in the common fourth character .3 is complicated by delirium as defined in F05. Convulsions may also occur. When organic factors are also considered to play a role in the etiology, the condition should be classified to F05.8.
Delirium tremens (alcohol-induced)
Active Ingredient | Description | |
---|---|---|
Buprenorphine |
Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence. |
|
Haloperidol |
Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. |
|
Mannitol |
Mannitol is a naturally occurring sugar alcohol used clinically primarily for its osmotic diuretic properties. |
|
Naloxone |
Naloxone hydrochloride, a semisynthetic morphine derivative (N-allyl-nor-oxymorphone), is a specific opioid antagonist that acts competitively at opioid receptors. It reveals very high affinity for the opioid receptor sites and therefore displaces both opioid agonists and partial antagonists, such as pentazocine, for example, but also nalorphine. |
|
Tiapride |
Tiapride is an atypical neuroleptic which exhibits selectivity in in-vitro studies for D2 and D3 dopamine subtype receptors without any affinity for subtype receptors of the principal central neurotransmitters (including serotonin, noradrenaline and histamine). |